Skip to content

Watin Biolife

by Watin Biolife Manufacturing Company Saudi Arabia EUDAMED

Ref 2046

EMDN W0104010499

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number628704495007BMBTY Basic UDI-DIDate5 May 2025RegisteredStatusWithdrawn Not intended for the EU market

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Withdrawn
  • Not covered

European Union — CE/IVDR Withdrawn

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 25 Oct 2026

Device Name
Brucella Modified Blood Agar
Model / Reference
2046
Primary DI / UDI-DI
06287044950070
Basic UDI-DI
628704495007BMBTY
EMDN Code
W0104010499 Prepared media in plates - other
Device Class
Class A

Manufacturer details

EUDAMED SRN
SA-MF-000047358
Authorised representative
Advena Limited MT-AR-000000234

Other devices from Watin Biolife Manufacturing Company

See all devices from Watin Biolife Manufacturing Company →

Properties & raw data

Show properties, registry sources and raw records
  • Professional Testing
Other properties (10)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (1)

  • EUDAMED d11e9c23-713a-4104-80ae-44f69400d237 61 fields · synced 25 Oct 2026